Dyadic International Inc. (DYAI) vs NewcelX Ltd. (NCEL)

Dyadic International Inc. and NewcelX Ltd. are both Biotechnology companies. Dyadic International Inc. and NewcelX Ltd. are of similar size ($14.5M and $14.0M). NewcelX Ltd. has the higher net margin (0.00% vs −226.9%) and the higher return on invested capital (0.00% vs 0.00%). Across the 11 metrics below, NewcelX Ltd. leads on 7 and Dyadic International Inc. on 4.

Valuation

Metric DYAI NCEL Biotechnology median
P/E n/m n/m 11.36
P/S 3.97 n/m 9.12
P/B n/m 4.76 2.14
Price to free cash flow n/m n/m 26.34
EV/EBITDA n/m n/m 0.62
EV/Sales 4.09 n/m 8.56
Earnings yield (65.63%) (59.30%) (34.18%)
Free cash flow yield (58.32%) (17.06%) (23.62%)

Profitability

Metric DYAI NCEL Biotechnology median
Gross margin 17.85% 0.00% 67.24%
Operating margin (237.12%) — 0.00%
Net margin (226.87%) 0.00% 0.00%
Free cash flow margin (227.93%) 0.00% 0.00%
Return on equity (47,310.78%) 0.00% (50.28%)
Return on assets (71.43%) 0.00% (45.89%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric DYAI NCEL Biotechnology median
Revenue growth (TTM) (7.64%) — 6.96%
EPS growth (last fiscal year) (15.00%) 11.18% 29.86%
Revenue growth, 5-year CAGR 14.04% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DYAI NCEL Biotechnology median
Debt to equity 0.00 0.06 0.00
Current ratio 1.69 0.40 4.72
Net debt to EBITDA 0.49 0.74 1.01

Dividend

Metric DYAI NCEL Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric DYAI NCEL Biotechnology median
Market cap 14.02m 14.48m 167.45m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack